FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

REGISTER

now for free

Michele Wible

Research Profile

Chemicals & Drugs

Disorders

Procedures

Concepts & Ideas

Living Beings

Candida

Register to see full profile

Co-author Network

Register to see all co-authors

Publications

TOP 3
Annette C Reboli; Coleman Rotstein; Peter G Pappas; Stanley W Chapman; Daniel H Kett; Deepali Kumar; Robert Betts; Michele Wible; Beth P Goldstein; Jennifer Schranz; David S Krause; THOMAS WALSH
Anidulafungin versus fluconazole for invasive candidiasis.
David S Krause; A E Simjee; Christo van Rensburg; Johann Viljoen; THOMAS WALSH; Beth P Goldstein; Michele Wible; Timothy Henkel
A randomized, double-blind trial of anidulafungin versus fluconazole for the treatment of esophageal candidiasis.
David S Krause; John Reinhardt; Jose A Vazquez; Annette C Reboli; Beth P Goldstein; Michele Wible; Timothy Henkel
Phase 2, randomized, dose-ranging study evaluating the safety and efficacy of anidulafungin in invasive candidiasis and candidemia.

Register to see all publications

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Register to see more

Geonetwork of Michele Wible (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Register to see more

All Publications

2007: Annette C Reboli; Coleman Rotstein; Peter G Pappas; Stanley W Chapman; Daniel H Kett; Deepali Kumar; Robert Betts; Michele Wible; Beth P Goldstein; Jennifer Schranz; David S Krause; THOMAS WALSH
Anidulafungin versus fluconazole for invasive candidiasis.
The New England journal of medicine 2007;356(24):2472-82.
2004: David S Krause; A E Simjee; Christo van Rensburg; Johann Viljoen; THOMAS WALSH; Beth P Goldstein; Michele Wible; Timothy Henkel
A randomized, double-blind trial of anidulafungin versus fluconazole for the treatment of esophageal candidiasis.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;39(6):770-5.
2004: David S Krause; John Reinhardt; Jose A Vazquez; Annette C Reboli; Beth P Goldstein; Michele Wible; Timothy Henkel
Phase 2, randomized, dose-ranging study evaluating the safety and efficacy of anidulafungin in invasive candidiasis and candidemia.
Antimicrobial agents and chemotherapy 2004;48(6):2021-4.

Register to see more

Copyright © 2011 Elsevier Inc. All rights reserved.